KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Gross Margin (2016 - 2026)

Amgen has reported Gross Margin over the past 18 years, most recently at 68.16% for Q1 2026.

  • For Q1 2026, Gross Margin rose 458.0% year-over-year to 68.16%; the TTM value through Mar 2026 reached 104.96%, up 3247.0%, while the annual FY2025 figure was 96.43%, 3490.0% up from the prior year.
  • Gross Margin for Q1 2026 was 68.16% at Amgen, down from 178.54% in the prior quarter.
  • Over five years, Gross Margin peaked at 178.54% in Q4 2025 and troughed at 280.61% in Q4 2022.
  • A 5-year average of 60.67% and a median of 73.84% in 2023 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: tumbled -44696bps in 2022 and later soared 34264bps in 2023.
  • Year by year, Gross Margin stood at 280.61% in 2022, then skyrocketed by 122bps to 62.03% in 2023, then increased by 6bps to 65.75% in 2024, then skyrocketed by 172bps to 178.54% in 2025, then crashed by -62bps to 68.16% in 2026.
  • Business Quant data shows Gross Margin for AMGN at 68.16% in Q1 2026, 178.54% in Q4 2025, and 67.75% in Q3 2025.